0001181431-13-036819.txt : 20130626 0001181431-13-036819.hdr.sgml : 20130626 20130626180653 ACCESSION NUMBER: 0001181431-13-036819 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130625 FILED AS OF DATE: 20130626 DATE AS OF CHANGE: 20130626 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANGECKER PETER CENTRAL INDEX KEY: 0001282829 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 13935545 MAIL ADDRESS: STREET 1: C/O INTARCIA THERAPEUTICS, INC. STREET 2: 2000 POWELL ST., SUITE 1640 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 rrd384346.xml X0306 4 2013-06-25 0 0000908259 OXIGENE INC OXGN 0001282829 LANGECKER PETER C/O OXIGENE, INC. 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Chief Executive Officer Common Stock, par value $0.01 per share 2013-06-25 4 P 0 2000 2.786 A 2000 D /s/ Megan N. Gates, attorney-in-fact 2013-06-26